Similar articles

• Methadone maintenance vs. implantable naltrexone treatment in the pregnant heroin user.

  Hulse GK, O'Neil G, Arnold-Reed DE. Hulse GK, et al. Int J Gynaecol Obstet. 2004 May;85(2):170-1. doi: 10.1016/j.ijgo.2003.10.001. Int J Gynaecol Obstet. 2004. PMID: 15099783 No abstract available.
• A pilot study of naltrexone-accelerated detoxification in opioid dependence.

  Bell JR, Young MR, Masterman SC, Morris A, Mattick RP, Bammer G. Bell JR, et al. Med J Aust. 1999 Jul 5;171(1):26-30. doi: 10.5694/j.1326-5377.1999.tb123493.x. Med J Aust. 1999. PMID: 10451668 Clinical Trial.
• Naltrexone-assisted rapid methadone discontinuation: a pilot study.

  Camarasa X, Khazaal Y, Besson J, Zullino DF. Camarasa X, et al. Eur Addict Res. 2007;13(1):20-4. doi: 10.1159/000095811. Eur Addict Res. 2007. PMID: 17172775
• Naltrexone in the treatment of heroin dependence: relationship with depression and risk of overdose.

  Ritter AJ. Ritter AJ. Aust N Z J Psychiatry. 2002 Apr;36(2):224-8. doi: 10.1046/j.1440-1614.2002.01012.x. Aust N Z J Psychiatry. 2002. PMID: 11982544 Review.
• [Naltrexone--prevention of recurrence in narcotic dependence and in alcoholism].

  Poser W, Ehrenreich H. Poser W, et al. Internist (Berl). 1996 Oct;37(10):1061-7; discussion 1067. Internist (Berl). 1996. PMID: 9019453 Review. German. No abstract available.